VistaGen Therapeutics, Inc.
VTGN
$1.97
-$0.08-3.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -75.12% | -47.51% | -11.52% | 28.43% | 50.44% |
| Total Depreciation and Amortization | 11.80% | 10.22% | 9.10% | 7.07% | 6.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 79.43% | -37.83% | -48.71% | -58.09% | -68.62% |
| Change in Net Operating Assets | 500.25% | 760.63% | 186.57% | 144.38% | -60.88% |
| Cash from Operations | -63.08% | -48.36% | -6.35% | 30.86% | 48.08% |
| Capital Expenditure | -213.11% | -312.50% | -1,212.00% | -179.13% | 71.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -21,454.10% | -2,347.14% | -2,363.27% | -878.58% | 91.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 100.06% | 30.79% | 4.74% |
| Issuance of Common Stock | -97.53% | -99.03% | 1,180,363.64% | 843,088.31% | 77,372.84% |
| Repurchase of Common Stock | -- | -75,900.00% | -75,900.00% | -75,900.00% | -75,900.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -200.23% | -211.97% | 100.00% |
| Cash from Financing | -97.50% | -99.32% | 172.02% | 79,610.90% | 12,434.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -150.75% | -151.07% | 1,909.31% | 320.22% | 299.10% |